Due to the ongoing shortage of BCG, gemcitabine has been increasingly used for first-line NMIBC therapy. N-803’s ability to activate natural killer and CD8+ T cells, thus the innate immune system, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback